Literature DB >> 10234016

Muscarinic control of cytoskeleton in perisynaptic glia.

J Georgiou1, R Robitaille, M P Charlton.   

Abstract

Similar to astrocytes at CNS synapses, perisynaptic Schwann cells (PSCs) surround nerve terminals at the neuromuscular junction (NMJ). These special teloglial cells are sensitive to neurotransmitters and upregulate glial fibrillary acidic protein (GFAP) when deprived of synaptic activity. We found that activation of muscarinic acetylcholine receptors (mAChRs) at PSCs, but not purinergic (ATP and adenosine) or peptidergic [substance P (SP) and calcitonin gene-related peptide (CGRP)] receptors, prevented this upregulation. When applied onto single PSCs, muscarine evoked Ca2+ responses that fatigued but prevented upregulation of this glial cytoskeletal protein. Application of ATP onto single PSCs evoked Ca2+ signals that showed little fatigue, and GFAP upregulation occurred. Thus, Ca2+ signals alone cannot prevent GFAP upregulation in the PSCs. After blockade of cholinergic receptors by gallamine, neuronal activity was not effective in maintaining low GFAP levels in the perisynaptic glia. Last, immunohistochemistry disclosed mAChRs on PSCs and nearby fibroblasts. Thus, acetylcholine secreted by the nerve terminal acts on the PSCs via mAChRs to regulate GFAP. Cytoskeletal changes may influence perisynaptic glial functions, including growth, remodeling, and modulation of the synapse.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10234016      PMCID: PMC6782737     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  68 in total

1.  Calcium oscillations increase the efficiency and specificity of gene expression.

Authors:  R E Dolmetsch; K Xu; R S Lewis
Journal:  Nature       Date:  1998-04-30       Impact factor: 49.962

Review 2.  Ion channels in vertebrate glia.

Authors:  B A Barres; L L Chun; D P Corey
Journal:  Annu Rev Neurosci       Date:  1990       Impact factor: 12.449

3.  Induced transmitter release from Schwann cells and its suppression by actinomycin D.

Authors:  S Bevan; R Miledi; W Grampp
Journal:  Nat New Biol       Date:  1973-01-17

4.  Three-dimensional reconstructions of astroglia and oligodendroglia cells.

Authors:  J Spacek
Journal:  Z Zellforsch Mikrosk Anat       Date:  1971

Review 5.  Astrocyte responses to CNS injury.

Authors:  M D Norenberg
Journal:  J Neuropathol Exp Neurol       Date:  1994-05       Impact factor: 3.685

Review 6.  Metabolic coupling between glia and neurons.

Authors:  M Tsacopoulos; P J Magistretti
Journal:  J Neurosci       Date:  1996-02-01       Impact factor: 6.167

Review 7.  Intermediate filaments: a chemically heterogeneous, developmentally regulated class of proteins.

Authors:  E Lazarides
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

8.  The relationship of glial fibrillary acidic protein to the shape, motility, and differentiation of human astrocytoma cells.

Authors:  P E Duffy; Y Y Huang; M M Rapport
Journal:  Exp Cell Res       Date:  1982-05       Impact factor: 3.905

9.  Purinergic receptors and their activation by endogenous purines at perisynaptic glial cells of the frog neuromuscular junction.

Authors:  R Robitaille
Journal:  J Neurosci       Date:  1995-11       Impact factor: 6.167

10.  Rapid and reversible astrocytic reaction to afferent activity blockade in chick cochlear nucleus.

Authors:  K S Canady; E W Rubel
Journal:  J Neurosci       Date:  1992-03       Impact factor: 6.167

View more
  19 in total

1.  Synapse-glia interactions at the mammalian neuromuscular junction.

Authors:  D Rochon; I Rousse; R Robitaille
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

Review 2.  Perisynaptic Schwann Cells at the Neuromuscular Synapse: Adaptable, Multitasking Glial Cells.

Authors:  Chien-Ping Ko; Richard Robitaille
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-08-20       Impact factor: 10.005

Review 3.  New perspectives on amyotrophic lateral sclerosis: the role of glial cells at the neuromuscular junction.

Authors:  Danielle Arbour; Christine Vande Velde; Richard Robitaille
Journal:  J Physiol       Date:  2016-12-01       Impact factor: 5.182

4.  In vivo long-term synaptic plasticity of glial cells.

Authors:  Eve-Lyne Bélair; Joanne Vallée; Richard Robitaille
Journal:  J Physiol       Date:  2010-02-08       Impact factor: 5.182

5.  Increased neuromuscular activity reduces sprouting in partially denervated muscles.

Authors:  S L Tam; V Archibald; B Jassar; N Tyreman; T Gordon
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

6.  Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter.

Authors:  Elsa Tremblay; Éric Martineau; Richard Robitaille
Journal:  J Neurosci       Date:  2017-08-11       Impact factor: 6.167

Review 7.  Clinical relevance of terminal Schwann cells: An overlooked component of the neuromuscular junction.

Authors:  Katherine B Santosa; Alexandra M Keane; Albina Jablonka-Shariff; Bianca Vannucci; Alison K Snyder-Warwick
Journal:  J Neurosci Res       Date:  2018-03-13       Impact factor: 4.164

8.  Cholinergic activation of enteric glia is a physiological mechanism that contributes to the regulation of gastrointestinal motility.

Authors:  Ninotchska M Delvalle; David E Fried; Gretchen Rivera-Lopez; Luke Gaudette; Brian D Gulbransen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-06-21       Impact factor: 4.052

9.  Distinct muscarinic acetylcholine receptor subtypes contribute to stability and growth, but not compensatory plasticity, of neuromuscular synapses.

Authors:  Megan C Wright; Srilatha Potluri; Xueyong Wang; Eva Dentcheva; Dinesh Gautam; Alan Tessler; Jürgen Wess; Mark M Rich; Young-Jin Son
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

10.  Properties of Glial Cell at the Neuromuscular Junction Are Incompatible with Synaptic Repair in the SOD1G37R ALS Mouse Model.

Authors:  Éric Martineau; Danielle Arbour; Joanne Vallée; Richard Robitaille
Journal:  J Neurosci       Date:  2020-08-28       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.